US Gaza planning, Haiti threats and media crackdowns underscore brittle power balances and a strained rules-based order.
Trump's WHO exit, abortion rule expansion and ICE fight deepen partisan clashes over health, immigration and power.
Oil, AI stocks and ultra-tight credit spreads signal risk-on markets even as investors hedge inflation and rate uncertainty.
NIH funding shifts, gutted panels and new disease insights reveal science caught between politics and rapid discovery.
Renewed fetal tissue funding ban jolts labs and reignites battles over science, ethics and ideology.
Coaching moves, FBI probes and a 1bn tennis revolt reshape power across football, soccer and global sport.